Adult ADHD

Myth: ADHD Medication Leads to Addiction

· 6 min read

Last updated

Myth: ADHD Medication Leads to Addiction
Disclaimer. This article is educational and is not medical, legal, or financial advice. It does not replace an individual evaluation or the guidance of your own clinician. Do not start, stop, or change any medication without talking to your prescriber. If you are in crisis, call or text 988 or go to the nearest emergency room.

Series: ADHD Myths · Part 2 of 6

  1. Myth: ADHD Is Overdiagnosed. What the Numbers Actually Show
  2. Myth: ADHD Medication Leads to Addiction
  3. Myth: You Cannot Have ADHD If You Did Well in School
  4. Myth: ADHD Is Just an Excuse for Laziness
  5. Myth: Children Grow Out of ADHD
  6. Myth: ADHD Is Caused by Sugar, Screens, or Bad Parenting

Parents hesitate to medicate children, and adults hesitate to medicate themselves, for one reason above others: the fear that a stimulant will lead to addiction. It is a fair concern about a Schedule II drug. It is also, on the evidence, backward. Part two of the myths series.

Untreated ADHD is the risk factor

ADHD itself roughly doubles the lifetime risk of substance use disorder. The mechanisms are impulsivity, sensation seeking, self-medication of symptoms, and the accumulated consequences of school and social failure. This baseline risk is what any treatment has to be compared against, and it is the part of the picture the myth leaves out.

What the large studies found

Registry studies following hundreds of thousands of people with ADHD, and long-term follow-ups of treated and untreated children, have consistently found that stimulant treatment is associated with lower, not higher, rates of later substance use disorder, or at worst no difference. A 2014 Swedish study found substance abuse events were 31 percent lower during periods on medication than off. Meta-analyses of childhood treatment find no increase in later substance use and some evidence of protection. Treating the ADHD appears to reduce the impulsivity and failure that drive the substance risk.

Why the myth persists

Stimulants can be misused: crushed, snorted, taken in high doses for euphoria, and diverted to people without prescriptions. This is real and is the subject of the misuse risk article. But therapeutic oral doses of long-acting formulations, taken as prescribed, produce slow and steady drug levels that do not generate the reinforcing rush associated with addiction. The pharmacology of a prescribed morning capsule and a crushed immediate-release tablet is different, and the myth conflates them.

Where caution is warranted

A personal or family history of substance use disorder is a reason for care: a prescriber may prefer a long-acting stimulant or a non-stimulant, monitor more closely, and involve a counselor. Active substance use disorder should generally be addressed before or alongside stimulant treatment. Adolescents and college students need explicit guidance about not sharing medication. None of this argues against treatment; it argues for treatment that accounts for the individual's risk.

Dependence versus addiction

People sometimes use the word addiction for the fact that symptoms return when medication stops. That is not addiction; it is the medication no longer being present, as with glasses removed. Addiction involves compulsive use despite harm, escalating doses, and loss of control. Prescribed stimulant use does not typically produce these, and stopping stimulants does not produce a dangerous withdrawal syndrome.

The bottom line

Untreated ADHD roughly doubles substance use risk; treated ADHD reduces it. Misuse of stimulants is real and is a reason for careful prescribing and screening, not a reason to withhold treatment from people who need it. Next myth: that good grades rule out ADHD.

Sources

Chang, Z., et al. (2014). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885.

Humphreys, K. L., Eng, T., & Lee, S. S. (2013). Stimulant medication and substance use outcomes: A meta-analysis. JAMA Psychiatry, 70(7), 740–749.

Quinn, P. D., et al. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174(9), 877–885.

Faraone, S. V., et al. (2021). The World Federation of ADHD International Consensus Statement. Neuroscience & Biobehavioral Reviews, 128, 789–818.

Educational content only. Nothing here is a substitute for individual assessment or medical advice.

Wondering whether it’s ADHD?

Take the free 5-minute screener, or learn about comprehensive ADHD testing in Grand Rapids and Byron Center, Michigan, and virtually statewide.

Free ADHD screenerADHD testingPrintable symptom checklist

Get the next one by email

Living With ADHD from a Christian Perspective — one short, practical email a week, plus two free guides when you join.

Join the newsletter